Location: Home
  • search
  • go
  • Relate News
  • 3/5/2021Junshi Initiates Toripalimab Rolling BLA Submission for Nasopharyngeal...
  • 3/5/2021Premier Delivers Government Work Report at the NPC Session (with Summa...
  • 3/5/2021Recent Executive Moves
  • 3/4/2021GSK Granted Approval for 2nd Indication of Lamictal Dispersible Tablet...
  • 3/4/2021NHC: China Achieves Phased Success with Its Tiered Medical System Buil...
  • 3/4/2021DSM Wins Patent Case against China’s Anhui Tiger Vitamin
  • 3/4/2021Amgen Buys Five Prime to Expand in Asia-Pacific’s Oncology Market
  • 3/4/2021Abcam Expands in China to Meet Increased Demand of BioPharma Sector
  • 3/4/2021Antitrust in China – 2020 Year in Review
  • 3/3/2021 Innoforce and dMed Collaborate to Accelerate the Development of Innov...
  • 3/3/2021Merck and Guangzhou Pharma Sign MOU for Alliance in GD-HK-Macao Greate...
  • 3/3/2021NMPA Revises Packages Inserts of Tramadol Injection and Single-ingredi...
  • 3/3/2021Sun Pharma's NDA for Odomzo (Sonidegib) to be Granted Priority Review
  • 3/3/2021ADC Developer Suzhou Medilink Therapeutics Secures $50M in A1 Financin...
  • 3/2/2021ADC Developer Suzhou Medilink Therapeutics Secures $50M in A1 Financin...
  • 3/2/2021NMPA Withdraws Approvals of 226 Drug Products Including 12 MNC Product...
  • 3/2/2021WuXi AppTec Completes Acquisition of Gene Therapy CRDO OXGENE
  • 3/1/2021Bayer Signs Strategic Alliance MOU with China Alliance for Rare Diseas...
  • 3/1/2021Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
  • 3/1/2021Eisai Secures Anti-Insomnia Drug Dayvigo in Hong Kong
  • 2/26/2021241 A Share-Listed Chinese MedPharm Cos Release 2020 Performance Guida...
  • 2/26/2021Recent Executive Moves
  • 2/26/2021NMPA Announces Package Insert Revision of Misoprostol Tablets
  • 2/26/2021CANbridge Pharma and Puma Biotech Agree to Terminate NERLYNX License...
  • 2/25/2021AstraZeneca Gains Default Chinese IND Approval for Its Class 1 New Bio...
  • 2/25/2021Snapshot of BMI System Financial Performance in 2020
  • 2/25/2021Puma Biotech and Pierre Fabre Amend NERLYNX License Deal to Include G...
  • 2/25/2021Harbour BioMed Announces Chinese IND Approval of for Combo Therapy of ...
  • 2/24/2021Review of Chinese Import Chemical Drug IND Applications in 2020
  • 2/24/2021Snapshot of MNC Products in the 2020 NRDL
  • Page:99/360 Total number of articles:10791: [First][<<] [97] [98] [99] [100] [101] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group